Trial run: FDA launches pilot for expedited INDs

Experts agree that the FDA's expedited IND programme is the most beneficial development from Operation Trialblazer. Experts agree that the expedited IND programme is the most beneficial development from Operation Trialblazer. The expedited IND review is part of Operation Trialblazer. Credit: Poetra.RH / Shutterstock.com The US Food and Drug Administration (FDA) is set to launch its expedited investigational new drug (IND) pilot as it targets matching Australia and China in Phase I trials. This pilot scheme comes as part of Operation Trialblazer, a scheme in which the US is trying to reduce its current two-year Phase I trial timeline to…

Source: Clinical Trials Arena